These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Low doses of EPO activate MAP kinases but not JAK2-STAT5 in rat vascular smooth muscle cells. Ammarguellat F; Llovera M; Kelly PA; Goffin V Biochem Biophys Res Commun; 2001 Jun; 284(4):1031-8. PubMed ID: 11409898 [TBL] [Abstract][Full Text] [Related]
10. Erythropoietin and Friend virus gp55 activate different JAK/STAT pathways through the erythropoietin receptor in erythroid cells. Yamamura Y; Senda H; Kageyama Y; Matsuzaki T; Noda M; Ikawa Y Mol Cell Biol; 1998 Mar; 18(3):1172-80. PubMed ID: 9488432 [TBL] [Abstract][Full Text] [Related]
11. Signaling induced by erythropoietin and stem cell factor in UT-7/Epo cells: transient versus sustained proliferation. Erickson-Miller CL; Pelus LM; Lord KA Stem Cells; 2000; 18(5):366-73. PubMed ID: 11007921 [TBL] [Abstract][Full Text] [Related]
12. Involvement of Jak2 tyrosine phosphorylation in Bcr-Abl transformation. Xie S; Wang Y; Liu J; Sun T; Wilson MB; Smithgall TE; Arlinghaus RB Oncogene; 2001 Sep; 20(43):6188-95. PubMed ID: 11593427 [TBL] [Abstract][Full Text] [Related]
13. Epo-induced hemoglobinization of SKT6 cells is mediated by minimal cytoplasmic domains of the Epo or prolactin receptors without modulation of GATA-1 or EKLF. Reese TT; Gregory RC; Sharlow ER; Pacifici RE; Crouse JA; Todokoro K; Wojchowski DM Growth Factors; 1997; 14(2-3):161-76. PubMed ID: 9255607 [TBL] [Abstract][Full Text] [Related]
14. STAT5 activation correlates with erythropoietin receptor-mediated erythroid differentiation of an erythroleukemia cell line. Iwatsuki K; Endo T; Misawa H; Yokouchi M; Matsumoto A; Ohtsubo M; Mori KJ; Yoshimura A J Biol Chem; 1997 Mar; 272(13):8149-52. PubMed ID: 9079629 [TBL] [Abstract][Full Text] [Related]
15. [Proliferative signal transmission mediated by EpoR in leukemic cell lines]. Fan H; Kanji S; Zhai M Zhonghua Xue Ye Xue Za Zhi; 2000 Jun; 21(6):294-7. PubMed ID: 11876995 [TBL] [Abstract][Full Text] [Related]
16. Angiotensin II activates Stat5 through Jak2 kinase in cardiac myocytes. McWhinney CD; Dostal D; Baker K J Mol Cell Cardiol; 1998 Apr; 30(4):751-61. PubMed ID: 9602424 [TBL] [Abstract][Full Text] [Related]
17. STAT5A interacts with and is phosphorylated upon activation of the mu-opioid receptor. Mazarakou G; Georgoussi Z J Neurochem; 2005 May; 93(4):918-31. PubMed ID: 15857395 [TBL] [Abstract][Full Text] [Related]
18. Erythropoietin-induced erythroid differentiation of the human erythroleukemia cell line TF-1 correlates with impaired STAT5 activation. Chrétien S; Varlet P; Verdier F; Gobert S; Cartron JP; Gisselbrecht S; Mayeux P; Lacombe C EMBO J; 1996 Aug; 15(16):4174-81. PubMed ID: 8861946 [TBL] [Abstract][Full Text] [Related]
19. Erythropoietin induces activation of Stat5 through association with specific tyrosines on the receptor that are not required for a mitogenic response. Quelle FW; Wang D; Nosaka T; Thierfelder WE; Stravopodis D; Weinstein Y; Ihle JN Mol Cell Biol; 1996 Apr; 16(4):1622-31. PubMed ID: 8657137 [TBL] [Abstract][Full Text] [Related]
20. Association of JAK2 and STAT5 with erythropoietin receptors. Role of receptor phosphorylation in erythropoietin signal transduction. Sawyer ST; Penta K J Biol Chem; 1996 Dec; 271(50):32430-7. PubMed ID: 8943308 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]